Lilly - November 2023 - Case Study 2

Start date:

Developing a pathway for the early and accurate diagnosis of Alzheimer’s Disease (AD) including biomarker assessment via cerebrospinal fluid (CSF)

Last modified: 22 March 2024

Last reviewed: 22 March 2024